Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

Bibliographic Details
Main Authors: Mathieu, Chantal, Hollander, Priscilla, Miranda-Palma, Bresta, Cooper, John, Franek, Edward, Russell-Jones, David, Larsen, Jens, Tamer, Søren Can, Bain, Stephen C.
Format: Online
Language:English
Published: Endocrine Society 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612802/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612802/

Similar Items